ライブ

Endpoints NewsPost-Hoc Live: Makary's out at FDA and what comes next CellThe immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis FierceBiotechNovartis, amid reorg, cuts ‘select number’ of biomedical research roles PharmaVoiceSanofi’s vaccine bump; the new FDA commish Endpoints NewsAardvark's next move after clinical hold; Alumis' verdict on Acelyrin asset FierceBiotechWhy Model Medicines needs to ‘discover new colors’ in its AI drug discovery quest BioPharma DiveIndia’s pharma industry is going global. But can it catch up to China?BioWorldSanofi identifies YAP1/TEAD and TAZ/TEAD interaction inhibitors BioWorldCSPC Megalith Biopharmaceutical discloses new CDCP1-targeting ADCs BioWorldAntelope Therapeutics patents new antibody-drug conjugates for cancer BioWorldHangzhou Institute of Medicine discovers new CDK2/cyclin E1 inhibitors BioWorldNew KRAS mutant inhibitors reported in Université de Montréal patent

Labiotech 2026年5月15日

CAR-T therapy for stiff person syndrome nears approval

No medicines have been approved for stiff person syndrome yet. However, Kyverna Therapeutics' CAR-T cell therapy is headed towards approval. The post CAR-T ther...

No medicines have been approved for stiff person syndrome yet. However, Kyverna Therapeutics' CAR-T cell therapy is headed towards approval. The post CAR-T therapy for stiff person syndrome nears approval appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.